Claudia Azucena Palafox‐Sánchez

Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus

Diana Celeste Salazar‐Camarena, Pablo Cesar Ortiz‐Lazareno, Álvaro Cruz et al. · Lupus · 2015 · 139 citations

Life Sciences, Immunology, Pathology +17

Macrophage migration inhibitory factor (MIF): Genetic evidence for participation in early onset and early stage rheumatoid arthritis

Mara Anaís Llamas-Covarrubias, Yeminia Valle, Richard Bucala et al. · Cytokine · 2013 · 79 citations

Life Sciences, Genetics, Immunology +12

Oxidized low-density lipoprotein and β2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis

Luis R. Lopez, Mario Salazar-Páramo, Claudia Azucena Palafox‐Sánchez et al. · Lupus · 2006 · 72 citations

Life Sciences, Immunology, Pathobiology +17

Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features

Zyanya Reyes-Castillo, Claudia Azucena Palafox‐Sánchez, Isela Parra‐Rojas et al. · Clinical & Experimental Immunology · 2015 · 59 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Oxidized Low-Density Lipoprotein/β₂-Glycoprotein I Complexes and Autoantibodies to oxLig-1/β₂-Glycoprotein I in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome

Daniel Lopez, Ignacio García-Valladares, Claudia Azucena Palafox‐Sánchez et al. · American Journal of Clinical Pathology · 2004 · 55 citations · Full text

Life Sciences, Immunology, Molecular Biology +15